Problems of the Use of Pseudoephedrine by Athletes

Abstract

Pseudoephedrine (PSE) as a sympathomimetic is an ingredient of many proprietary medicines which are available on the medical market over the counter (OTC drugs). It can be converted to cathine (CATH, norpseudoephedrine) inside the body. Until the end of 2003, PSE had been a banned substance in sport in case its urinary concentration was greater than 25 μg/ml. Then the World Anti-Doping Agency (WADA) removed PSE from the prohibited list. Prior to 2004 CATH was a forbidden substance and it is still one. CATH is included on the WADA prohibited list in the group of stimulants. The results of a doping control concerning PSE conducted in the Department of Anti-Doping Research of Institute of Sport in Warsaw in the years 2001–2003 and 2004–2007 have been compared. Moreover, several dozen of urine samples collected from the patients taking OTC drugs with PSE have been analysed. In these samples the concentration of PSE and CATH has been estimated. The results of this study have shown that athletes were using PSE frequently and in high doses between 2004 and 2007 when this substance was permitted by WADA. It is possible that athletes can obtain a positive result of doping control with CATH after the use of PSE.

Key words

pseudoephedrine - cathine - doping - sport

References

• 1 Bents RT, Tokish JM, Goldberg L. Ephedrine, pseudoephedrine, and amphetamine prevalence in college hockey players. Most report performance-enhancing use.  Phys Sportsmed. 2004;  32 30-34
• 2 Cantu C, Arauz A, Murillo-Bonilla LM, López M, Barinagarrementeria F. Stroke associated with sympathomimetics contained in over-the-counter cough and cold drugs.  Stroke. 2003;  34 1667-1673
• 3 Chester N, Reilly T, Mottram DR. Physiological, subjective and performance effects of pseudoephedrine and phenylpropanolamnie during running exercise.  Int J Sports Med. 2003;  24 3-8
• 4 Chu KS, Doherty TJ, Parise G, Milheiro JS, Tarnopolsky MA. A moderate dose of pseudoephedrine does not alter muscle contraction strength or anaerobic power.  Clin J Sport Med. 2002;  12 387-390
• 5 Delbeke FT, Debackere M. Urinary concentrations of codeine and morphine after the administration of different codeine preparations in relation to doping analysis.  J Pharm Biomed Anal. 1991;  9 959-964
• 6 Franklin QJ. Sudden death after typhoid and Japanese encephalitis vaccination in a young male taking pseudoephedrine.  Mil Med. 1999;  164 157-159
• 7 Geyer H, Parr MK, Mareck U, Reinhart U, Schrader Y, Schänzer W. Analysis of non-hormonal nutritional supplements for anabolic androgenic steroids – Results of an international study.  Int J Sports Med. 2004;  25 124-129
• 8 Gill ND, Shield A, Blazevich AJ, Zhou S, Weatherby RP. Muscular and cardiorespiratory effects of pseudoephedrine in human athletes.  Br J Clin Pharmacol. 2000;  50 205-213
• 9 Gillies H, Derman WE, Noakes TD, Smith P, Evans A, Gabriels G. Pseudoephedrine is without ergogenic effects during prolonged exercise.  J Appl Physiol. 1996;  81 2611-2617
• 10 Hodges K, Hancock S, Currell K, Hamilton B, Jeukendrup AE. Pseudoephedrine enhances performance in 1500-m runners.  Med Sci Sports Exerc. 2006;  38 329-333
• 11 Kicman AT, Cowan DA, Myhre L, Nilsson S, Tomten S, Oftebro H. Effect on sports drug tests of ingesting meat from steroid (methenolone)-treated livestock.  Clin Chem. 1994;  40 2084-2087
• 12 Kwiatkowska D, Grucza R, Chrostowski K, Smorawiñski J. Doping cases in Polish athletes.  Biol Sport. 2000;  17 121-131
• 13 Lai W, Xu Y, Fung DYC, Xiong Y. Development of a lateral-flow assay for rapid screening of the performance – enhancing sympathomimetic drug clenbuterol used in animal production; food safety assessments.  Asia Pac J Clin Nutr. 2007;  16 ((Suppl 1)) 106-110
• 14 Marinetti L, Lehman L, Casto B, Harshbarger K, Kubiczek P, Davis J. Over-the-counter cold medications-postmortem findings in infants and the relationship to cause of death.  J Anal Toxicol. 2005;  29 738-743
• 15 MedlinePlus Drug Information: Pseudoephedrine . http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682619.html , ,access date: 10.10.2008
• 16 Moffat AC, Osselton MD, Widdop B. eds Clarke's Analysis of Drugs and Poisons. Third edition. London – Chicago: Pharmaceutical Press 2004: 1504-1505
• 17 Orchard JW, Fricker PA, White SL, Burke LM, Healey DJ. The use and misuse of performance-enhancing substances in sport.  Med J Aust. 2006;  184 132-136
• 18 Pokrywka A, Obmiñski Z, Stañczyk D, Kwiatkowska D, Grucza R. Caffeine use by Polish athletes before and after removal of caffeine from the doping list.  Polish J Sports Med. 2007;  23 326-331 , (in Polish, English abstract)
• 19 Thevis M, Opfermann G, Schänzer W. Urinary concentrations of morphine and codeine after consumption of poppy seeds.  J Anal Toxicol. 2003;  27 53-56
• 20 Tseng YL, Hsu HR, Kuo FH, Shieh MH, Chang CF. Ephedrines in over-the-counter cold medicines and urine specimens collected during sport competitions.  J Anal Toxicol. 2003;  27 359-365
• 21 Tseng YL, Shieh MH, Kuo FH. Metabolites of ephedrines in human urine after administration of a single therapeutic dose.  Forensic Sci Int. 2006;  157 149-155
• 22 Van Eenoo P, Delbeke FT, Roels K, De Backer P. Simultaneous quantitation of ephedrines in urine by gas chromatography-nitrogen-phosphorus detection for doping control purposes.  J Chromatogr B. 2001;  760 255-261
• 23 Van Thuyne W, Van Eenoo P, Delbeke FT. Nutritional supplements: prevalence of use and contamination with doping agents.  Nutr Res Rev. 2006;  19 147-158
• 24 Van Thuyne W, Van Eenoo P, Delbeke FT. Urinary concentration of morphine after the administration of herbal teas containing Papaveris fructus in relation to doping analysis.  J Chromatogr B. 2003;  785 245-251
• 25 WADA Statistics 2003 . Overview of results reported by the 31 IOC/WADA-accredited Laboratories. , WADA Montreal: http://www.wada-ama.org/rtecontent/document/LABSTATS_2003.pdf , access date: 01.10.2008
• 26 WADA Technical Document – TD2009MRPL . WADA Laboratory Committee, September 20, 2008.  , WADA Montreal: http://www.wada-ama.org/rtecontent/document/MINIMUM_REQUIRED_PERFORMANCE_LEVELS_TD_v1_0_january_2009.pdf , access date: 17.12.2008
• 27 Wingert WE, Mundy LA, Collins GL, Chmara ES. Possible role of pseudoephedrine and other over-the-counter cold medications in the deaths of very young children.  J Forensic Sci. 2007;  52 487-490
• 28 Yonamine M, Garcia PR, de Moraes Moreau RL. Non-intentional doping in sports.  Sports Med. 2004;  34 697-704

Correspondence